As of 30 Sep 2025, 321 institutional investors reported holding 85,200,989 shares of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 558,359 | $8,716,808 | -$640,505 | $15.59 | 31 |
| 2025 Q3 | 85,200,989 | $1,247,351,823 | +$106,200,552 | $14.64 | 321 |
| 2025 Q2 | 77,806,509 | $1,202,785,823 | +$106,862,917 | $15.46 | 307 |
| 2025 Q1 | 71,086,493 | $1,057,034,943 | -$156,054 | $14.87 | 300 |
| 2024 Q4 | 72,039,413 | $953,847,647 | -$55,374,045 | $13.24 | 295 |
| 2024 Q3 | 71,553,169 | $1,015,380,211 | +$20,521,956 | $14.22 | 295 |
| 2024 Q2 | 72,061,993 | $940,730,985 | -$86,515,519 | $12.94 | 281 |
| 2024 Q1 | 78,179,293 | $1,087,229,460 | -$73,198,839 | $13.89 | 310 |
| 2023 Q4 | 83,396,860 | $1,190,086,769 | +$34,664,126 | $14.27 | 302 |
| 2023 Q3 | 80,437,115 | $1,242,500,598 | -$66,352,882 | $15.47 | 310 |
| 2023 Q2 | 84,017,983 | $1,320,003,579 | -$935,677 | $15.71 | 308 |
| 2023 Q1 | 82,262,152 | $1,355,589,943 | +$248,962,456 | $16.48 | 296 |
| 2022 Q4 | 68,069,757 | $1,063,701,562 | +$48,470,698 | $15.60 | 278 |
| 2022 Q3 | 63,905,792 | $829,049,514 | +$90,138,783 | $12.97 | 258 |
| 2022 Q2 | 56,978,507 | $799,748,914 | +$66,260,391 | $14.04 | 258 |
| 2022 Q1 | 56,159,628 | $802,855,152 | -$261,335,589 | $14.32 | 265 |
| 2021 Q4 | 75,991,152 | $1,037,422,048 | -$299,110,798 | $13.63 | 271 |
| 2021 Q3 | 91,971,894 | $1,505,006,212 | -$51,986,093 | $16.38 | 274 |
| 2021 Q2 | 94,938,677 | $1,598,252,322 | -$223,745,245 | $16.83 | 287 |
| 2021 Q1 | 107,728,479 | $1,962,038,029 | -$1,144,218 | $18.26 | 300 |
| 2020 Q4 | 108,743,491 | $1,978,272,193 | +$47,411,066 | $18.20 | 291 |
| 2020 Q3 | 107,411,892 | $1,906,842,183 | -$74,858,671 | $17.84 | 296 |
| 2020 Q2 | 111,608,181 | $2,000,687,993 | -$67,870,563 | $17.93 | 291 |
| 2020 Q1 | 115,527,636 | $1,755,033,222 | -$255,328,027 | $15.18 | 290 |
| 2019 Q4 | 129,903,867 | $2,564,492,170 | -$263,257,024 | $19.73 | 323 |
| 2019 Q3 | 142,713,146 | $2,453,745,858 | -$10,944,466 | $17.20 | 296 |
| 2019 Q2 | 144,969,953 | $2,567,070,888 | -$508,563,867 | $17.70 | 323 |
| 2019 Q1 | 178,446,454 | $3,633,871,563 | +$2,339,014,740 | $20.37 | 365 |
| 2018 Q4 | 53,778,088 | $908,062,778 | +$853,769,936 | $16.82 | 82 |
| 2018 Q3 | 2,916,735 | $62,341,000 | +$9,168,044 | $21.37 | 15 |
| 2018 Q2 | 2,487,812 | $52,101,000 | +$10,712,473 | $20.90 | 14 |
| 2018 Q1 | 1,890,639 | $46,133,000 | +$5,629,927 | $24.41 | 10 |
| 2017 Q4 | 1,659,165 | $47,189,000 | +$7,825,480 | $28.22 | 9 |
| 2017 Q3 | 1,383,979 | $38,304,326 | +$9,532,340 | $27.40 | 8 |
| 2017 Q2 | 1,039,668 | $26,417,135 | +$3,307,044 | $25.06 | 8 |
| 2017 Q1 | 909,540 | $21,474,985 | +$7,409,653 | $23.24 | 8 |
| 2016 Q4 | 598,950 | $12,441,746 | +$257,312 | $20.78 | 7 |
| 2016 Q3 | 586,683 | $14,032,000 | +$3,276,840 | $23.81 | 6 |
| 2016 Q2 | 449,689 | $9,685,809 | -$5,868,979 | $21.54 | 7 |
| 2016 Q1 | 722,721 | $16,489,917 | +$3,753,417 | $22.82 | 8 |
| 2015 Q4 | 558,023 | $13,979,103 | +$8,524,753 | $25.00 | 9 |
| 2015 Q3 | 231,769 | $5,065,000 | -$7,911,819 | $21.87 | 9 |
| 2015 Q2 | 556,403 | $13,466,000 | +$636,075 | $24.16 | 8 |
| 2015 Q1 | 529,554 | $13,251,000 | +$1,844,508 | $25.00 | 8 |
| 2014 Q4 | 455,916 | $9,476,000 | -$83,574 | $20.84 | 8 |
| 2014 Q3 | 459,996 | $10,000,000 | +$530,656 | $21.75 | 8 |
| 2014 Q2 | 435,563 | $10,116,000 | -$6,899,910 | $23.19 | 7 |
| 2014 Q1 | 726,088 | $17,232,000 | -$1,435,931 | $23.75 | 9 |